DCZ0415

DCZ0415, a potent TRIP13 inhibitor, impairs nonhomologous end joining repair and inhibits NF-κB activity. DCZ0415 induces anti-myeloma activity.

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
50mg	500	In-stock
100mg	700	In-stock
250mg	1250	In-stock
500mg	2200	In-stock
1g	3800	In-stock
5g	get quote	Inquire

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670


CAS No.	2242470-43-3
Purity	>98%
Formula	C23H20N2O2
Mol Weight	356.4171
Color	Off-white to yellow
State	solid powder
Solubility	Soluble in DMSO 62.5 mg/mL
Shelf Life	>2 years if stored properly
Storage	Powder -20℃ 2 years; In solvent -20℃ 1 month;
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1]. Wang Y, et al. A Small Molecule Inhibitor Targeting TRIP13 suppresses multiple myeloma progression. Cancer Res. 2019 Nov 15. pii: canres.3987.2018.
CoA	CoA of DCZ0415


		Search